• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化脓性链球菌的血清混浊因子(SOF)可诱发抗体,这些抗体可调理A群链球菌的同源和异源SOF阳性血清型。

Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous SOF-positive serotypes of group A streptococci.

作者信息

Courtney Harry S, Hasty David L, Dale James B

机构信息

Veterans Affairs Medical Center and Department of Medicine, University of Tennessee, Memphis, Tennessee 38104, USA.

出版信息

Infect Immun. 2003 Sep;71(9):5097-103. doi: 10.1128/IAI.71.9.5097-5103.2003.

DOI:10.1128/IAI.71.9.5097-5103.2003
PMID:12933852
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC187301/
Abstract

Serum opacity factor (SOF) is a protein expressed by Streptococcus pyogenes that opacifies mammalian serum. SOF is also a virulence factor of S. pyogenes, but it has not been previously shown to elicit a protective immune response. Herein, we report that SOF evokes bactericidal antibodies against S. pyogenes in humans, rabbits, and mice. Rabbit antiserum against purified recombinant SOF2 opsonized SOF-positive M type 2, 4, and 28 S. pyogenes in human blood but had no effect on SOF-negative M type 5 S. pyogenes. Furthermore, affinity-purified human antibodies against SOF2 also opsonized SOF-positive streptococci. A combination of antisera against M2 and SOF2 proteins was dramatically more effective in killing streptococci than either antiserum alone, indicating that antibodies against SOF2 enhance the opsonic efficiency of M protein antibodies. Mice tolerated an intravenous injection of 100 microg of SOF without overt signs of toxicity, and immunization with SOF protected mice against challenge infections with M type 2 S. pyogenes. These data indicate that SOF evokes opsonic antibodies that may protect against infections by SOF-positive serotypes of group A streptococci and suggest that different serotypes of SOF have common epitopes that may be useful vaccine candidates to protect against group A streptococcal infections.

摘要

血清混浊因子(SOF)是化脓性链球菌表达的一种可使哺乳动物血清变混浊的蛋白质。SOF也是化脓性链球菌的一种毒力因子,但此前尚未证明它能引发保护性免疫反应。在此,我们报告SOF能在人、兔和小鼠体内诱发针对化脓性链球菌的杀菌抗体。抗纯化重组SOF2的兔抗血清可调理人血中SOF阳性的2型、4型和28型化脓性链球菌,但对SOF阴性的5型化脓性链球菌无作用。此外,亲和纯化的抗SOF2人抗体也能调理SOF阳性的链球菌。抗M2和SOF2蛋白的抗血清组合在杀死链球菌方面比单独使用任何一种抗血清都显著有效,这表明抗SOF2抗体可提高M蛋白抗体的调理效率。小鼠能耐受静脉注射100微克SOF且无明显毒性迹象,用SOF免疫可保护小鼠免受2型化脓性链球菌的攻击感染。这些数据表明,SOF能诱发调理抗体,可能对A组链球菌SOF阳性血清型感染起到保护作用,并提示不同血清型的SOF具有共同表位,可能是预防A组链球菌感染的有用候选疫苗。

相似文献

1
Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous SOF-positive serotypes of group A streptococci.化脓性链球菌的血清混浊因子(SOF)可诱发抗体,这些抗体可调理A群链球菌的同源和异源SOF阳性血清型。
Infect Immun. 2003 Sep;71(9):5097-103. doi: 10.1128/IAI.71.9.5097-5103.2003.
2
Immunological response mounted by Aboriginal Australians living in the Northern Territory of Australia against Streptococcus pyogenes serum opacity factor.居住在澳大利亚北领地的澳大利亚原住民对化脓性链球菌血清混浊因子产生的免疫反应。
Microbiology (Reading). 2002 Jan;148(Pt 1):169-78. doi: 10.1099/00221287-148-1-169.
3
Opacity factor activity and epithelial cell binding by the serum opacity factor protein of Streptococcus pyogenes are functionally discrete.化脓性链球菌血清混浊因子蛋白的混浊因子活性和上皮细胞结合功能是不相关的。
J Biol Chem. 2008 Mar 7;283(10):6359-66. doi: 10.1074/jbc.M706739200. Epub 2008 Jan 7.
4
Serum opacity factor is a major fibronectin-binding protein and a virulence determinant of M type 2 Streptococcus pyogenes.血清混浊因子是一种主要的纤连蛋白结合蛋白,也是M2型化脓性链球菌的一种毒力决定因素。
Mol Microbiol. 1999 Apr;32(1):89-98. doi: 10.1046/j.1365-2958.1999.01328.x.
5
Intranasal immunization with serum opacity factor (SOF) of Streptococcus pyogenes fails to protect mice against lethal mucosal challenge with a heterologous strain.用化脓性链球菌的血清混浊因子(SOF)进行鼻内免疫,无法保护小鼠免受异源菌株致死性粘膜攻击。
Vaccine. 2006 Feb 27;24(9):1446-50. doi: 10.1016/j.vaccine.2005.06.039. Epub 2005 Sep 29.
6
emm and sof gene sequence variation in relation to serological typing of opacity-factor-positive group A streptococci.与不透明因子阳性A群链球菌血清学分型相关的emm和sof基因序列变异
Microbiology (Reading). 2000 May;146 ( Pt 5):1195-1209. doi: 10.1099/00221287-146-5-1195.
7
Serum opacity factor is a streptococcal receptor for the extracellular matrix protein fibulin-1.血清混浊因子是细胞外基质蛋白纤维连接蛋白-1的一种链球菌受体。
J Biol Chem. 2009 May 8;284(19):12966-71. doi: 10.1074/jbc.M901143200. Epub 2009 Mar 10.
8
Preparation of specific antisera to the opacity factors of group-A streptococci.A群链球菌透明质酸酶特异性抗血清的制备。
J Med Microbiol. 1982 May;15(2):153-62. doi: 10.1099/00222615-15-2-153.
9
New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci.新型 30 价 M 蛋白疫苗引发针对 A 组链球菌非疫苗血清型的交叉调理抗体。
Vaccine. 2011 Oct 26;29(46):8175-8. doi: 10.1016/j.vaccine.2011.09.005. Epub 2011 Sep 13.
10
SfbII protein, a fibronectin binding surface protein of group A streptococci, is a serum opacity factor with high serotype-specific apolipoproteinase activity.SfbII蛋白是A组链球菌的一种纤连蛋白结合表面蛋白,是一种具有高血清型特异性载脂蛋白酶活性的血清混浊因子。
FEMS Microbiol Lett. 1999 Sep 15;178(2):305-11. doi: 10.1111/j.1574-6968.1999.tb08692.x.

引用本文的文献

1
Multiple bacterial virulence factors focused on adherence and biofilm formation associate with outcomes in cirrhosis.多种与黏附和生物膜形成相关的细菌毒力因子与肝硬化的结局相关。
Gut Microbes. 2021 Jan-Dec;13(1):1993584. doi: 10.1080/19490976.2021.1993584.
2
A brief review on Group A Streptococcus pathogenesis and vaccine development.A 组链球菌发病机制与疫苗研发简述
R Soc Open Sci. 2021 Mar 10;8(3):201991. doi: 10.1098/rsos.201991.
3
Novel Models of Colonization and Disease Reveal Modest Contributions of M-Like (SCM) Protein.新型殖民化与疾病模型揭示了M样(SCM)蛋白的微小贡献。
Microorganisms. 2021 Jan 16;9(1):183. doi: 10.3390/microorganisms9010183.
4
Cross-serotype protection against group A Streptococcal infections induced by immunization with SPy_2191.免疫 SPy_2191 可诱导针对 A 群链球菌感染的交叉型保护。
Nat Commun. 2020 Jul 15;11(1):3545. doi: 10.1038/s41467-020-17299-x.
5
Streptococcus pyogenes genes that promote pharyngitis in primates.促进灵长类动物咽炎的化脓性链球菌基因。
JCI Insight. 2020 Jun 4;5(11):137686. doi: 10.1172/jci.insight.137686.
6
Vaccine Approaches To Protect against Group A Streptococcal Pharyngitis.疫苗接种预防 A 组链球菌咽炎的方法。
Microbiol Spectr. 2019 May;7(3). doi: 10.1128/microbiolspec.GPP3-0010-2018.
7
Contribution of cryptic epitopes in designing a group A streptococcal vaccine.设计 A 组链球菌疫苗中隐匿表位的作用。
Hum Vaccin Immunother. 2018;14(8):2034-2052. doi: 10.1080/21645515.2018.1462427. Epub 2018 Jun 14.
8
Towards developing a vaccine for rheumatic heart disease.致力于研发一种用于风湿性心脏病的疫苗。
Glob Cardiol Sci Pract. 2017 Mar 31;2017(1):e201704. doi: 10.21542/gcsp.2017.4.
9
Opacification Domain of Serum Opacity Factor Inhibits Beta-Hemolysis and Contributes to Virulence of .血清混浊因子的混浊区域抑制β-溶血并有助于……的毒力
mSphere. 2017 Apr 19;2(2). doi: 10.1128/mSphereDirect.00147-17. eCollection 2017 Mar-Apr.
10
Complement inhibition by Sarcoptes scabiei protects Streptococcus pyogenes - An in vitro study to unravel the molecular mechanisms behind the poorly understood predilection of S. pyogenes to infect mite-induced skin lesions.疥螨的补体抑制作用可保护化脓性链球菌——一项体外研究,旨在揭示化脓性链球菌易感染螨诱导皮肤损伤这一尚不清楚的偏好背后的分子机制。
PLoS Negl Trop Dis. 2017 Mar 9;11(3):e0005437. doi: 10.1371/journal.pntd.0005437. eCollection 2017 Mar.

本文引用的文献

1
Persistence of type-specific antibodies in man following infection with group A streptococci.A 组链球菌感染后人体中特异性抗体的持续存在。
J Exp Med. 1959 Aug 1;110(2):271-92. doi: 10.1084/jem.110.2.271.
2
Protection against group A streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protection.用J8-白喉类毒素免疫预防A组链球菌:J8特异性抗体和白喉类毒素特异性抗体对保护作用的贡献。
J Infect Dis. 2003 May 15;187(10):1598-608. doi: 10.1086/374800. Epub 2003 Apr 30.
3
Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS).与链球菌感染相关的儿童自身免疫性神经精神障碍(PANDAS)
Mol Psychiatry. 2002;7 Suppl 2:S24-5. doi: 10.1038/sj.mp.4001170.
4
Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999.1995 - 1999年美国侵袭性A组链球菌疾病的流行病学
Clin Infect Dis. 2002 Aug 1;35(3):268-76. doi: 10.1086/341409. Epub 2002 Jul 10.
5
Molecular mechanisms of adhesion, colonization, and invasion of group A streptococci.A 组链球菌黏附、定植和侵袭的分子机制
Ann Med. 2002;34(2):77-87. doi: 10.1080/07853890252953464.
6
Protection of mice from group A streptococcal infection by intranasal immunisation with a peptide vaccine that contains a conserved M protein B cell epitope and lacks a T cell autoepitope.通过鼻内免疫含有保守M蛋白B细胞表位且缺乏T细胞自身表位的肽疫苗来保护小鼠免受A组链球菌感染。
Vaccine. 2002 Jun 21;20(21-22):2816-25. doi: 10.1016/s0264-410x(02)00205-0.
7
A lipid core peptide construct containing a conserved region determinant of the group A streptococcal M protein elicits heterologous opsonic antibodies.一种含有A组链球菌M蛋白保守区域决定簇的脂质核心肽构建体可引发异源调理抗体。
Infect Immun. 2002 May;70(5):2734-8. doi: 10.1128/IAI.70.5.2734-2738.2002.
8
Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection (PANDAS).对患有与A组链球菌感染相关的儿童自身免疫性神经精神障碍(PANDAS)的儿童进行前瞻性识别和治疗。
Arch Pediatr Adolesc Med. 2002 Apr;156(4):356-61. doi: 10.1001/archpedi.156.4.356.
9
Mapping the fibrinogen-binding domain of serum opacity factor of group a streptococci.绘制A组链球菌血清混浊因子的纤维蛋白原结合结构域图谱。
Curr Microbiol. 2002 Apr;44(4):236-40. doi: 10.1007/s00284-001-0037-1.
10
Immunogenicity of a 26-valent group A streptococcal vaccine.一种26价A群链球菌疫苗的免疫原性。
Infect Immun. 2002 Apr;70(4):2171-7. doi: 10.1128/IAI.70.4.2171-2177.2002.